Strategic Investments
Strategic Investments
More value than your share price reflects.
We’re built to unlock it.
More value than your share price reflects. We’re
built to unlock it.
More value than your share price reflects. We’re built to unlock it.
More value than your share price reflects.
We’re built to unlock it.
Transforming public equity into ownership in a disciplined, well-capitalised holding company.
Altuva acquires control positions in listed companies trading below intrinsic value. All-stock consideration. 60–90 days to close.
Altuva acquires control positions in listed companies trading below intrinsic value. All-stock consideration. 60–90 days to close.
Our Mandate
Our Mandate
Patient capital. Premium pricing. Control positions in listed companies.
Patient capital. Premium pricing. Control positions in listed companies.
The discount persists because capital cannot
self-correct without control.
The discount persists because capital cannot
self-correct without control.
Market dynamics often create a persistent valuation gap. Altuva offers a board-friendly solution.
A premium,
on day one.
A premium,
on day one.
A premium,
on day one.
Altuva equity consideration is priced above your current market price at announcement. Shareholders receive a liquid, institutionally-backed position. Not a thinly-traded stub in a standalone company carrying the same structural constraints.
Altuva equity consideration is priced above your current market price at announcement. Shareholders receive a liquid, institutionally-backed position. Not a thinly-traded stub in a standalone company carrying the same structural constraints.
Altuva equity consideration is priced above your current market price at announcement. Shareholders receive a liquid, institutionally-backed position. Not a thinly-traded stub in a standalone company carrying the same structural constraints.
Patient capital.
No forced exit.
Patient capital.
No forced exit.
Patient capital.
No forced exit.
No fund vintage, no redemption pressure, no LP distribution requirements that force a premature sale. We hold as long as value creation demands. We exit when it maximises shareholder value, not when a clock says we must.
No fund vintage, no redemption pressure, no LP distribution requirements that force a premature sale. We hold as long as value creation demands. We exit when it maximises shareholder value, not when a clock says we must.
No fund vintage, no redemption pressure, no LP distribution requirements that force a premature sale. We hold as long as value creation demands. We exit when it maximises shareholder value, not when a clock says we must.
Equity as currency.
No contingency.
Equity as currency.
No contingency.
Equity as currency.
No contingency.
All-stock consideration removes financing risk, accelerates close, and aligns our cost of capital with the target’s existing shareholders. A board-supported transaction can close in 60–90 days from term sheet.
All-stock consideration removes financing risk, accelerates close, and aligns our cost of capital with the target’s existing shareholders. A board-supported transaction can close in 60–90 days from term sheet.
All-stock consideration removes financing risk, accelerates close, and aligns our cost of capital with the target’s existing shareholders. A board-supported transaction can close in 60–90 days from term sheet.
OUR APPROACH
OUR APPROACH
Three commitments
Three commitments
We bring the same approach to every company
we partner with, in every sector.
We bring the same approach to every company
we partner with, in every sector.
Market dynamics often create a persistent valuation gap. Altuva offers a board-friendly solution.
01
01
01
01
We acquire established companies.
We acquire established companies.
A friendly, board-
supported process
Profitable businesses with durable customer relationships and disciplined operations.
Profitable businesses with durable customer relationships and disciplined operations.
Profitable businesses with durable customer relationships and disciplined operations.
02
02
02
02
We hold them
permanently.
We hold them
permanently.
We hold them permanently.
We hold them
permanently.
No fund vintage. No exit clock. We own for the long term, not the next auction.
No fund vintage. No exit clock. We own for the long term, not the next auction.
No fund vintage. No exit clock. We own for the long term, not the next auction.
03
03
03
03
We invest in what's
already working.
We invest in what's
already working.
We invest in what's already working.
Long-term upside as an
Altuva partner
Management, culture, and customer relationships stay. We support the people who built the business.
Management, culture, and customer relationships stay. We support the people who built the business.
Management, culture, and customer relationships stay. We support the people who built the business.
Investment Platforms
Investment Platforms
Five sector verticals.
One structural thesis.
Five sector verticals.
One structural thesis.
The same business quality that earns 3–5× EBITDA as a standalone listed
company earns 8–12× as part of a scaled, institutionally-covered platform.
Each platform has its own leadership and pipeline.
All share one balance sheet, one holding period,
one approach.
The same business quality that earns 3–5× EBITDA as a standalone listed
company earns 8–12× as part of a scaled, institutionally-covered platform.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
01
01
Technology & Software Value
Mature SaaS
Mature SaaS
Vertical Software
Vertical Software
Infrastructure Tools
Infrastructure Tools
Enterprise Platforms
Enterprise Platforms
Profitable software businesses trading at 1–3× revenue with positive free cash flow, orphaned by growth-only capital and ignored by strategics. The discount is structural, not operational.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
02
02
Biotech and Healthcare
Oncology
Oncology
Gene and Cell Therapy
Gene and Cell Therapy
CNS / Neurology
CNS / Neurology
Medical Devices
Medical Devices
Rare Diseases
Rare Diseases
A platform of clinical assets diversifies the single-program binary risk that keeps standalone biotechs priced at a fraction of pipeline value.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
03
03
Industrials & Advanced Manufacturing
Precision Manufacturing
Precision Manufacturing
Aerospace & Defense
Aerospace & Defense
Clean Technology
Clean Technology
Industrial Automation
Industrial Automation
The same EBITDA at $50M revenue trades at 4×. At $300M it trades at 8–12×. Scale is the only variable that changes.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
04
04
Materials & Natural Resources
Critical Minerals
Critical Minerals
Specialty Chemicals
Specialty Chemicals
Advanced Materials
Advanced Materials
Steel & Metals
Steel & Metals
Paper & Packaging
Paper & Packaging
Asset-heavy listed businesses priced as if their geology, IP, and infrastructure will never be monetised. Platform capital changes the calculus.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
05
05
Consumer Brands & Specialty Retails
Food & Beverage
Food & Beverage
Health & Wellness
Health & Wellness
Apparel & Footwear
Consumer Electronics
Consumer Services
Consumer Services
Profitable franchises trapped inside listco shells weighed down by loss-making international tails and public-market overhead. Strip the tail, capitalise the core, re-rate the brand.
Your shareholders transition from a single-assetrisk to an institutional-grade portfolio managed by specialists.
Ready to explore? It starts with a 30-minute call.
Ready to explore? It starts with a 30-minute call.
Ready to explore? It starts with a 30-minute call.
Ready to explore? It starts with a 30-minute call.
Where we partner
Where we partner
Where we partner
Moments where the right long-term partner matters
Moments where the right long-term partner matters
Most conversations start in
one of these three situations.
Most conversations start in
one of these three situations.
Founder Transitions
The next chapter of a founder-built company.
Carve-Outs
A divisional business stepping out on its own.
Public-to-Private
A quieter home for an established pubcos.
Structure A
Full Partnership
Exchange equity for Altuva shares and participate fully in the platform.
Ideal for: Clean transition with long-term upside
Structure B
IP and Business Unit Carve-Out
Retain your IP while Altuva acquires the public company shell and capital.
Ideal for: Teams building on their core innovation
Structure C
Hybrid: Partial Roll plus Retained Operations
A portion rolls into Altuva while management retains selected assets.
Ideal for: Complex cap tables or mixed objectives
The Structural Edge
The Structural Edge
Three things a financial buyer cannot offer.
Three things a financial buyer cannot offer.
No financing
contingency.
An all-stock merger closes as fast as a signed board resolution. There is no debt raise, syndication risk, or bridge financing to renegotiate.
Aligned holding
period.
Unlike private equity's 5-7 year exit horizon, Altuva's management teams do not plan for the next sale process. They plan for the next decade.
A platform built on the
re-rating thesis.
AMETEK built a $40B platform by acquiring 70+ niches at 3–5× EBITDA, re-rating them to 14–16×. Altuva replicates this playbook across 5 verticals.
Structure A
Full Partnership
Exchange equity for Altuva shares and participate fully in the platform.
Ideal for: Clean transition with long-term upside
Structure B
IP and Business Unit Carve-Out
Retain your IP while Altuva acquires the public company shell and capital.
Ideal for: Teams building on their core innovation
Structure C
Hybrid: Partial Roll plus Retained Operations
A portion rolls into Altuva while management retains selected assets.
Ideal for: Complex cap tables or mixed objectives
Illustrative Situation
Illustrative Situation
A profitable core.
A value-destroying tail.
A profitable core.
A value-destroying tail.
Anonymised archetype drawn from current 10-K filings. One of
dozens visible across Altuva’s pipeline. Not a disclosed transaction.
Your shareholders don't have to choose between cashing
out and staying invested. With Altuva, they can do both.
Anonymised archetype drawn from current 10-K filings. One of
dozens visible across Altuva’s pipeline. Not a disclosed transaction.
Your shareholders don't have to choose between cashing out and staying invested. With Altuva, they can do both.
The Company
The Company
The Company
A NASDAQ-listed branded consumer-goods business. A profitable franchise (~$600M revenue, +$57M operating income) trapped within a corporate shell whose international segment loses $11M annually and whose listco overhead consumes the rest.
A NASDAQ-listed branded consumer-goods business. A profitable franchise (~$600M revenue, +$57M operating income) trapped within a corporate shell whose international segment loses $11M annually and whose listco overhead consumes the rest.
Today · trapped
Today · trapped
~$150M
~$150M
~$150M
Market capitalisation
Market capitalisation
~$150M
~$150M
~$150M
Operating loss (FY)
Operating loss (FY)
($19.6M)
($19.6M)
($19.6M)
Loss streak
Loss streak
3 consecutive years
3 consecutive years
3 consecutive years
Public-market value
Public-market value
Capped at listco shell
Capped at listco shell
Capped at listco shell
Altuva structure · released
Altuva structure · released
~$600M
~$600M
~$600M
Net equity value
Net equity value
~$600M
~$600M
~$600M
Sum-of-parts (gross)
Sum-of-parts (gross)
$797M
$797M
$797M
Path to value
Path to value
Divest tail · capitalise core
Divest tail · capitalise core
Divest tail · capitalise core
Acquirer model
Acquirer model
Permanent-capital platform
Permanent-capital platform
Permanent-capital platform
Same business. Same assets. No operational change. The delta is the listco overhead, the loss-making tail, and the absence of a control acquirer.
Same business. Same assets. No operational change. The delta is the listco overhead, the loss-making tail, and the absence of a control acquirer.
Value Delta
Value Delta
+4.1×
+4.1×
Figures derived from FY2024 10-K filings of a publicly listed company in Altuva’s screening universe. ~30% response rate to friendly board approaches on situations of this profile.
Figures derived from FY2024 10-K filings of a publicly listed company in Altuva’s screening universe. ~30% response rate to friendly board approaches on situations of this profile.
Figures derived from FY2024 10-K filings of a publicly listed company in Altuva’s screening universe. ~30% response rate to friendly board approaches on situations of this profile.
Board exploring strategic options? Management team ready for a larger platform?
Every conversation starts with a 30-minute confidential call. No obligation, no public disclosure, and no disruption to your operations or shareholder base.
Every conversation starts with a 30-minute confidential call. No obligation, no public disclosure, and no disruption to your operations or shareholder base.
Every conversation starts with a 30-minute confidential call. No obligation, no public disclosure, and no disruption to your operations or shareholder base.